ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
NZ Trader
|
38 |
9.0K |
8 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
38
|
9.0K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Change of Director's Interest Notices x2
|
|
NZ Trader
|
11 |
3.7K |
12 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
11
|
3.7K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
11 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
978
|
265K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
NZ Trader
|
38 |
9.0K |
11 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
38
|
9.0K
|
11
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
NZ Trader
|
34 |
7.7K |
6 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
34
|
7.7K
|
6
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Kingsrose to Commence Drilling at Rana Project, Norway
|
|
NZ Trader
|
15 |
4.6K |
2 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
15
|
4.6K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
NZ Trader
|
34 |
7.7K |
6 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
7.7K
|
6
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
NZ Trader
|
34 |
7.7K |
11 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
7.7K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
14 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
978
|
265K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
NZ Trader
|
38 |
9.0K |
26 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
38
|
9.0K
|
26
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Kingsrose to Commence Drilling at Rana Project, Norway
|
|
NZ Trader
|
15 |
4.6K |
5 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
15
|
4.6K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
NZ Trader
|
34 |
7.7K |
10 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
34
|
7.7K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
15 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
978
|
265K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Change of Director's Interest Notices x2
|
|
NZ Trader
|
11 |
3.7K |
12 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
11
|
3.7K
|
12
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Kingsrose to Commence Drilling at Rana Project, Norway
|
|
NZ Trader
|
15 |
4.6K |
1 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
15
|
4.6K
|
1
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Kingsrose to Commence Drilling at Rana Project, Norway
|
|
NZ Trader
|
15 |
4.6K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
15
|
4.6K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
NZ Trader
|
107 |
27K |
16 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
27K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
NZ Trader
|
107 |
27K |
20 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
27K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
19 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
978
|
265K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
NZ Trader
|
107 |
27K |
11 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
27K
|
11
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
10 |
2.0K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
10
|
2.0K
|
2
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Kingsrose to Commence Drilling at Rana Project, Norway
|
|
NZ Trader
|
15 |
4.6K |
3 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
15
|
4.6K
|
3
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
10 |
2.0K |
4 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
10
|
2.0K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
NZ Trader
|
831 |
330K |
5 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
831
|
330K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
NZ Trader
|
831 |
330K |
10 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
831
|
330K
|
10
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
NZ Trader
|
117 |
30K |
12 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
117
|
30K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
NZ Trader
|
107 |
27K |
13 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
107
|
27K
|
13
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
NZ Trader
|
36 |
9.5K |
1 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
36
|
9.5K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
22 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
12 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Application for quotation of securities - BIT
|
|
NZ Trader
|
39 |
10K |
4 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
39
|
10K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
NZ Trader
|
36 |
9.5K |
3 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
36
|
9.5K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
8 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
NZ Trader
|
107 |
27K |
35 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
107
|
27K
|
35
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
10 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
16 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
16
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
NZ Trader
|
36 |
9.5K |
5 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
36
|
9.5K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
NZ Trader
|
117 |
30K |
8 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
117
|
30K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
22 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
978
|
265K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
12 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
7 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
10 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
12 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
12 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
9 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
15 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
15
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
NZ Trader
|
117 |
30K |
9 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
117
|
30K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
265K |
15 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
978
|
265K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
NZ Trader
|
297 |
85K |
15 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
297
|
85K
|
15
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Application for quotation of securities - BIT
|
|
NZ Trader
|
39 |
10K |
6 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
39
|
10K
|
6
|
|